Ian A. Cook, Md Dlfapa Fctmss
AeroLeads people directory · profile

Ian A. Cook, Md Dlfapa Fctmss Email & Phone Number

CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc.
Location: Los Angeles, California, United States 25 work roles 2 schools
1 work email found @ucla.edu 4 phones found area 310 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email i****@ucla.edu
Direct phone (310) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma.
Location
Los Angeles, California, United States

Who is Ian A. Cook, Md Dlfapa Fctmss? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ian A. Cook, Md Dlfapa Fctmss is listed as CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc., based in Los Angeles, California, United States. AeroLeads shows a work email signal at ucla.edu, phone signal with area code 310, and a matched LinkedIn profile for Ian A. Cook, Md Dlfapa Fctmss.

Ian A. Cook, Md Dlfapa Fctmss previously worked as CEO, Founder at Los Angeles Tms Institute, Inc. and Vice President, Founding Board Member at Foundation For The Advancement Of Clinical Tms. Ian A. Cook, Md Dlfapa Fctmss holds Md, Medicine from Yale School Of Medicine.

Company email context

Email format at Los Angeles TMS Institute, Inc.

This section adds company-level context without repeating Ian A. Cook, Md Dlfapa Fctmss's masked contact details.

*@ucla.edu
68% confidence

AeroLeads found 1 current-domain work email signal for Ian A. Cook, Md Dlfapa Fctmss. Compare company email patterns before reaching out.

Profile bio

About Ian A. Cook, Md Dlfapa Fctmss

Ian A. Cook, Md Dlfapa Fctmss is a CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc.. They possess expertise in neuroscience, clinical research, psychiatry, healthcare, treatment and 42 more skills. Colleagues describe them as "Dr. Cook has mastered the fusion of academic ingenuity, humility and collegial synergy. Present and future healthcare professionals can increase their positive influence by following his example."

Listed skills include Neuroscience, Clinical Research, Psychiatry, Healthcare, and 43 others.

Current workplace

Ian A. Cook, Md Dlfapa Fctmss's current company

Company context helps verify the profile and gives searchers a useful next step.

Los Angeles TMS Institute, Inc.
Los Angeles Tms Institute, Inc.
CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma.
AeroLeads page
25 roles · 37 years

Ian A. Cook, Md Dlfapa Fctmss work experience

A career timeline built from the work history available for this profile.

Ceo, Founder

Current

Providing advanced treatment options for depression and other disorders, with interventions including Transcranial Magnetic Stimulation (TMS), the SAINT protocol, and ketamine. By referral only. www.LATMS.com

Jul 2018 - Present

Professor Emeritus, Dept Of Psychiatry & Biobehavioral Sci, David Geffen Sch Of Medicine At Ucla

Current

Los Angeles, Ca, Us

Professor Emeritus July 2018 - Professor-in-Residence July 2010 - June 2018Associate Professor-in-Residence July 2003 - June 2010Assistant Professor-in-Residence July 1996 - June 2003Instructor July 1995 - June 1996* Innovating through translational neuroscience research* Promoting and providing evidence-based excellence in patient care* Teaching across multiple levels, from Continuing Education programs, to residents, medical students, undergraduates, and primary school students* Leading through administrative roles at the School of Medicine, in the Semel Institute, and in the Department of Psychiatry and Biobehavioral Sciences * See http://www.IanCook.com for details

Jul 1995 - Present

Chief Translational Innovation Officer, Semel Institute For Neuroscience And Human Behavior At Ucla

Los Angeles, Ca, Us

Facilitate and accelerate the identification, development, and commercialization of discoveries from the Semel Institute

Jul 2017 - Jun 2018

Attending Physician

Los Angeles, Ca, Us

Patient care for mental health

Jul 1994 - Jun 2018

Founding Chief, Transcranial Magnetic Stimulation Service

Los Angeles, Ca, Us

Founded this clinical service at UCLA, bringing this form of therapeutic neuromodulation to the UCLA community

May 2009 - May 2014

Chief Resident, Consultation-Liaison Psychiatry

Los Angeles, Ca, Us

Jul 1993 - Jun 1994

Chief Medical Officer, Senior Vice President (On Leave)

Current
Neurosigma, Inc.

NeuroSigma, Inc., is a Los Angeles-based life sciences company, established to develop neuromodulation technologies with the potential to transform medical practice and patients’ lives. The clinical focus has been neurological and neuropsychiatric disorders.Trigeminal Nerve Stimulation (TNS) is unique among neuromodulation therapies because it can be delivered via a non-invasive external trigeminal nerve stimulation (eTNS™) system, or a minimally-invasive subcutaneous trigeminal nerve stimulation (sTNS™) system. NeuroSigma is investigating TNS as a treatment for epilepsy, depression, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), Traumatic Brain Injury (TBI), and a rare, orphan disorder, Lennox-Gastaut Syndrome (LGS). One of the inventors of the core IP around TNS, I was Senior Medical Advisor to the company before becoming CMO and SVP in February 2014.Links to some representative activities:* PTSD http://t.co/7vU11T3uHB :: http://ucla.in/1PerckG :: http://bit.ly/22wxPve* ADHD http://mdgdgt.com/1lvcBu4* TBI http://bit.ly/1RJwsChCurrently on leave

Feb 2014 - Present

Member, Board Of Directors

Current

Fresno, California, Us

"By pooling together resources and experience, the Clinical TMS Society aims to optimize the administration of TMS, develop novel indications for treatment, expand insurance coverage, and increase public awareness of TMS around the world." http://www.ClinicalTMSSociety.orgCo-Chair, Legal, Business, and Ethics Committee 2017 - present

2013 - Present ~13 yrs 6 mos

Co-Founder

Los Angeles, California, Us

CEO and Chairman, Board of Directors 2018 - 2023.CMO 2023 - 2024HeartCloud.io unleashes the rich data collected via wearables and at-home sensors, and provides Insights into health and fitness for clinicians to provide higher quality remote care, through Remote Physiologic Monitoring and Remote Therapeutic Monitoring. HeartCloud for Health Practices (practices.heartcloud.io) gives providers access to the data with visualizations that cut through the noise and guide them to the key information - for better informed decisions, made more efficiently and profitably.https://practices.heartcloud.io

2018 - 2024 ~6 yrs

Psychiatrist, Mood Disorders And Tms Programs, Gla Va Health

Washington, Dc, Us

Working to deliver and improve mental health care for our Veterans

Sep 2016 - Jun 2018

Director, Ucla Neuromodulation Scholars Training Program

Ucla

This program trains psychiatrists to provide state-of-the-art neuromodulation treatments, focusing on the principles and practice of FDA-approved neuromodulation systems and investigational approaches that are in research and development. http://TMSLosAngeles.com/forms/NSTPCallForApplicants.pdfDavid Krantz, MD, PhD, is our inaugural Scholar

Jan 2014 - Jun 2018

Professor-In-Residence

Ucla Department Of Bioengineering

Teaching and establishing research collaborations among groups at UCLA, with a focus on neuromodulation and bioelectrical signals.

Jul 2013 - Jun 2018

Director, Ucla Depression Research & Clinic Program

Los Angeles, Ca, Us

Improve care for depression by (a) developing and improving new treatments such as new medications and neuromodulation methods (e.g., trigeminal nerve stimulation, transcranial magnetic stimulation (TMS)), (b) improving the use of current interventions such as using biomarkers to guide treatment planning, (c) catalyzing collaborative research in depression intramurally at UCLA and through extramural research partnering, (d) providing public education on depression and other mood disorders (twitter @moodresearch)

2007 - Jun 2018

Associate Director, Ucla Laboratory Of Brain, Behavior And Pharmacology

Ucla Semel Institute For Neuroscience And Human Behavior

Translational neuroscience research

1995 - 2018 ~23 yrs

Chair Of The Faculty And Faculty Executive Committee

David Geffen School Of Medicine At Ucla

Elected Representative of the School's Faculty for shared governance.

Sep 2011 - Sep 2013

Chief Of Staff

Resnick Neuropsychiatric Hospital At Ucla
Jul 2011 - Jun 2013

Joanne And George Miller And Family Chair In Depression Research

Ucla Brain Research Institute

Develop biomarkers to help guide the optimal use of existing treatments, and develop new treatments for mood disorders

May 2008 - Apr 2011

Member, Executive Committee On Practice Guidelines

Washington, Dc, Us

Development and dissemination of evidence-based practice guidelines

2002 - 2008 ~6 yrs

Chair, Psychiatry Department Curriculum Committee

David Geffen School Of Medicine At Ucla

Oversee and coordinate the didactic program for Residents in Psychiatry at UCLA

2005 - 2007 ~2 yrs

Nimh Research Fellow, Psychobiology Of Major Psychiatric And Psychosomatic Disorders

Ucla Neuropsychiatric Institute And Hospital

T32 MH17140

Jul 1993 - Jun 1996
2 education records

Ian A. Cook, Md Dlfapa Fctmss education

Md, Medicine

Yale School Of Medicine

B.S.E., Eecs & Bioengineering

Princeton University
FAQ

Frequently asked questions about Ian A. Cook, Md Dlfapa Fctmss

Quick answers generated from the profile data available on this page.

What company does Ian A. Cook, Md Dlfapa Fctmss work for?

Ian A. Cook, Md Dlfapa Fctmss works for Los Angeles TMS Institute, Inc..

What is Ian A. Cook, Md Dlfapa Fctmss's role at Los Angeles TMS Institute, Inc.?

Ian A. Cook, Md Dlfapa Fctmss is listed as CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc..

What is Ian A. Cook, Md Dlfapa Fctmss's email address?

AeroLeads has found 1 work email signal at @ucla.edu for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc..

What is Ian A. Cook, Md Dlfapa Fctmss's phone number?

AeroLeads has found 4 phone signal(s) with area code 310 for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc..

Where is Ian A. Cook, Md Dlfapa Fctmss based?

Ian A. Cook, Md Dlfapa Fctmss is based in Los Angeles, California, United States while working with Los Angeles TMS Institute, Inc..

What companies has Ian A. Cook, Md Dlfapa Fctmss worked for?

Ian A. Cook, Md Dlfapa Fctmss has worked for Los Angeles Tms Institute, Inc., Foundation For The Advancement Of Clinical Tms, Ucla Health System, Neurosigma, Inc., and Clinical Tms Society.

How can I contact Ian A. Cook, Md Dlfapa Fctmss?

You can use AeroLeads to view verified contact signals for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc., including work email, phone, and LinkedIn data when available.

What schools did Ian A. Cook, Md Dlfapa Fctmss attend?

Ian A. Cook, Md Dlfapa Fctmss holds Md, Medicine from Yale School Of Medicine.

What skills is Ian A. Cook, Md Dlfapa Fctmss known for?

Ian A. Cook, Md Dlfapa Fctmss is listed with skills including Neuroscience, Clinical Research, Psychiatry, Healthcare, Treatment, Mental Health, Medicine, and Medical Education.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.